Informationes plurimae ― Latine

Urticaria Vulgo munera cum scabioso intente livor attolluntur. Aliquando fit tumor substrata tela. Curatio imprimis implicat triggers evitandos, si notum est. Prima linea medicamen antihistamines recentiores includit, quae ad gustatu altiori, si opus fuerit, accommodari possunt. Alia medicamenta sicut antihistamina vetusta, H2 obstructores, leukotriene receptor antagonistarum, antihistaminum validiores, et cursus corticosteroidum brevibus subsidiis adici possunt. In casibus in quibus urticaria perseveret, non obstante his rationibus, aegros ad specialitas referri possunt ad therapias additas, sicut omalizumab vel cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Haec recensio novissimas viasque ad urticaria tractandas delineat et novas causas suarum intellectus praebet.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids